1. 1) Galasso G.J., Whitley R.J., Merigan T.C., “Antiviral Agents and Human Viral Diseases,” 4th ed., Lippincott-Raven Publishers, Philadelphia, 1997, pp. 369-413.
2. 2) Blair E., Darby G., Gough G., Littler E., Rowlands D., Tisdale M., “Antiviral Therapy,” BIOS Scientific Publishers, London, 1998, pp. 71-95.
3. 3) Kurokawa M., Ochiai H., Nagasaka K., Neki M., Xu H., Kadota S., Sutardjo S., Matsumoto T., Namba T., Shiraki K., Antiviral Res., 22, 175-188 (1993).
4. 4) Hayashi K., Nishino H., Niwayama S., Shiraki K., Hiramatsu A., Antiviral Res., 17, 323-333 (1992).
5. 5) Syddislis R.J., Owen D.G., Lophr J.L., Rosler K.H.A., Blomster R. N., Antimicrob. Agents Chemother., 35, 2363-2466 (1991).